Preformed Line Products Company - PLPC

PLPC Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
PLPC	-0.1	3.5	-0.2	0.6	1.3	-0.4	103.7	110.5	162.0	640.6
S&P 500	1.0	3.7	2.1	2.3	8.2	25.4	31.0	80.6	196.5	33856.2

Compare PLPC with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	PLPC
name	Preformed Line Products Company
price	125.9
changes percentage	-0.1348
change	-0.17
day low	124.7
day high	127.57
year high	145.28
year low	109.01
market cap	616607840
price avg 50	131.8744
price avg 200	126.27625
exchange	NASDAQ
volume	4832
avg volume	10445
open	127.57
previous close	126.07
eps	6.69
pe	18.82
earnings announcement	2025-03-05T10:59:00.000+0000
shares outstanding	4897600
timestamp	2025-01-17 21:00:01

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 69.3%

Overall Quarterly Financial Health: 48.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000080035
revenue	669679000	637021000	5.13
gross profit	234848000	215180000	9.14
gross profit ratio	0.35	0.34	3.82
research and development expenses	22481000	19661000	14.34
operating expenses	150694000	139290000	8.19
interest income	1811000	631000	187.00
interest expense	3905000	3214000	21.50
ebitda	105163000	93245000	12.78
ebitdaratio	0.16	0.13	19.88
operating income	84154000	69361000	21.33
operating income ratio	0.13	0.11	15.41
net income	63332000	54395000	16.43
net income ratio	0.09	0.09	10.75
eps	12.87	11.03	16.68

Overall Score of Annual Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 670 million in 2023 from 637 million in 2022 representing a change of 5.13%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 235 million in 2023 from 215 million in 2022 representing a change of 9.14%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 22 million in 2023 from 20 million in 2022 representing a change of 14.34%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 84 million in 2023 from 69 million in 2022 representing a change of 21.33%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 63 million in 2023 from 54 million in 2022 representing a change of 16.43%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 12.87 in 2023 from 12.87 in 2022 representing a change of 16.68%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 151 million in 2023 from 139 million in 2022 representing a change of 8.19%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 105 million in 2023 from 93 million in 2022 representing a change of 12.78%. The decrease in EBITDA indicates declined operational efficiency and profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000080035
revenue	146973000	138720000	5.95
gross profit	45778000	44273000	3.40
gross profit ratio	0.31	0.32	-2.41
research and development expenses	5545000	5358000	3.49
operating expenses	35386000	32981000	7.29
interest income	538000	346000	55.49
interest expense	564000	568000	-0.70
ebitda	16316000	16975000	-3.88
ebitdaratio	0.11	0.12	-6.88
operating income	10392000	11292000	-7.97
operating income ratio	0.07	0.08	-13.14
net income	7680000	9366000	-18.00
net income ratio	0.05	0.07	-22.61
eps	1.57	1.91	-17.80

Overall Score of Quarterly Income Statement

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 147 million in 2024Q3 from 139 million in 2024Q2 representing a change of 5.95%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 46 million in 2024Q3 from 44 million in 2024Q2 representing a change of 3.4%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 6 million in 2024Q3 from 5 million in 2024Q2 representing a change of 3.49%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 35 million in 2024Q3 from 33 million in 2024Q2 representing a change of 7.29%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 16 million in 2024Q3 from 17 million in 2024Q2 representing a change of -3.88%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 10 million in 2024Q3 from 11 million in 2024Q2 representing a change of -7.97%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 8 million in 2024Q3 from 9 million in 2024Q2 representing a change of -18.0%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1.57 in 2024Q3 from 1.57 in 2024Q2 representing a change of -17.8%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000080035
total assets	603151000	568479000	6.10
total liabilities	186995000	209855000	-10.89
total equity	416156000	358624000	16.04
cash and cash equivalents	53607000	37239000	43.95
short term investments	0	0	NaN
long term investments	0	0	NaN
total current assets	324815000	328170000	-1.02
total non current assets	278336000	240309000	15.82
total current liabilities	111317000	115335000	-3.48
total non current liabilities	75678000	94520000	-19.93
common stock	13607000	3090000	340.36
retained earnings	520154000	460930000	12.85
total debt	71813000	89536000	-19.79

Overall Score of Annual Balance Sheet

0.89 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 603 million in 2023 from 568 million in 2022 representing a change of 6.1%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 187 million in 2023 from 210 million in 2022 representing a change of -10.89%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 416 million in 2023 from 359 million in 2022 representing a change of 16.04%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 54 million in 2023 from 37 million in 2022 representing a change of 43.95%. This indicates an increase in available liquid assets.

  Total Current Liabilities: Total Current Liabilities decreased to 111 million in 2023 from 115 million in 2022 representing a change of -3.48%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 14 in 2023 from 3 in 2022 representing a change of 340.36%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 520 million in 2023 from 461 million in 2022 representing a change of 12.85%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 72 million in 2023 from 90 million in 2022 representing a change of -19.79%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Current Assets: Total Current Assets decreased to 325 million in 2023 from 328 million in 2022 representing a change of -1.02%. This indicates a worsen liquidity position.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000080035
total assets	591953000	572587000	3.38
total liabilities	162966000	156369000	4.22
total equity	428987000	416218000	3.07
cash and cash equivalents	47498000	47424000	0.16
short term investments	0	0	NaN
long term investments	-1611000	0	NaN
total current assets	320644000	305073000	5.10
total non current assets	271309000	267514000	1.42
total current liabilities	113999000	103984000	9.63
total non current liabilities	48967000	52385000	-6.52
common stock	13715000	13711000	0.03
retained earnings	543743000	537079000	1.24
total debt	43809000	47144000	-7.07

Overall Score of Quarterly Balance Sheet

0.78 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 592 million in 2024Q3 from 573 million in 2024Q2 representing a change of 3.38%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 429 million in 2024Q3 from 416 million in 2024Q2 representing a change of 3.07%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 47 million in 2024Q3 from 47 million in 2024Q2 representing a change of 0.16%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 321 million in 2024Q3 from 305 million in 2024Q2 representing a change of 5.1%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 14 in 2024Q3 from 14 in 2024Q2 representing a change of 0.03%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 544 million in 2024Q3 from 537 million in 2024Q2 representing a change of 1.24%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 44 million in 2024Q3 from 47 million in 2024Q2 representing a change of -7.07%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 163 million in 2024Q3 from 156 million in 2024Q2 representing a change of 4.22%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 114 million in 2024Q3 from 104 million in 2024Q2 representing a change of 9.63%. This indicates a higher short-term debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000080035
net change in cash	16368000	833000	1864.95
operating cash flow	107642000	26153000	311.59
free cash flow	72310000	-14445000	600.59
capital expenditure	-35332000	-40598000	12.97
depreciation and amortization	18914000	16430000	15.12
deferred income tax	-2232000	-2656000	15.96
stock based compensation	4948000	4596000	7.66
accounts payables	2302000	6707000	-65.68
inventory	-4952000	-36979000	86.61
acquisitions net	-12089000	-16235000	25.54
investments in property plant and equipment	-35332000	-40598000	12.97
net cash used for investing activites	-44790000	-46755000	4.20
debt repayment	-28088000	31301000	-189.74
common stock issued	2164000	808000	167.82
common stock repurchased	-18892000	-5467000	-245.56
dividends paid	-4106000	-4099000	-0.17
net cash used provided by financing activities	-48922000	22543000	-317.02
cash at end of period	53607000	37239000	43.95
accounts receivables	16969000	-28049000	160.50
cash at beginning of period	37239000	36406000	2.29

Overall Score of Annual Cashflow Statement

0.44 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 16 million in 2023 from 1 million in 2022 representing a change of 1864.95%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 108 million in 2023 from 26 million in 2022 representing a change of 311.59%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 72 million in 2023 from -14 million in 2022 representing a change of 600.59%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables decreased to 2 million in 2023 from 7 million in 2022 representing a change of -65.68%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -35 million in 2023 from -41 million in 2022 representing a change of 12.97%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to -2 million in 2023 from -3 million in 2022 representing a change of 15.96%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 5 million in 2023 from 5 million in 2022 representing a change of 7.66%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 17 in 2023 from -28 million in 2022 representing a change of 160.5%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -4 million in 2023 from -4 million in 2022 representing a change of -0.17%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000080035
operating cash flow	9366000	28294000	-66.90
free cash flow	5792000	24566000	-76.42
capital expenditure	-3574000	-3728000	4.13
depreciation and amortization	5322000	5246000	1.45
deferred income tax	-1099000	-1527000	28.03
stock based compensation	632000	934000	-32.33
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	128000	-100.00
investments in property plant and equipment	-3574000	-3728000	4.13
net cash used for investing activites	-3446000	-3600000	4.28
debt repayment	-4181000	-17813000	76.53
common stock issued	99000	1000	9800.00
common stock repurchased	-2233000	-569000	-292.44
dividends paid	-983000	-984000	0.10
net cash used provided by financing activities	-7298000	-21838000	66.58
net change in cash	74000	1565000	-95.27
cash at end of period	47498000	47424000	0.16
cash at beginning of period	47424000	45859000	3.41

Overall Score of Quarterly Cashflow Statement

0.29 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to 0 million in 2024Q3 from 2 million in 2024Q2 representing a change of -95.27%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 9 million in 2024Q3 from 28 million in 2024Q2 representing a change of -66.9%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 6 million in 2024Q3 from 25 million in 2024Q2 representing a change of -76.42%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -4 million in 2024Q3 from -4 million in 2024Q2 representing a change of 4.13%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to -1 million in 2024Q3 from -2 million in 2024Q2 representing a change of 28.03%. This indicates that the company's tax liability for future periods has increased.

• 📈 Positive Indicators

  Stock-Based Compensation: Stock-Based Compensation decreased to 1 million in 2024Q3 from 1 million in 2024Q2 representing a change of -32.33%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Dividends Paid: Dividends Paid increased to -1 million in 2024Q3 from -1 million in 2024Q2 representing a change of 0.1%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	136.11	129.19	5.36
net income per share	12.87	11.03	16.69
operating cash flow per share	21.88	5.3	312.51
free cash flow per share	14.7	-2.93	601.71
cash per share	10.9	7.55	44.28
book value per share	84.58	72.73	16.30
tangible book value per share	75.95	64.19	18.32
shareholders equity per share	84.59	72.73	16.30
interest debt per share	15.39	18.81	-18.18
market cap	658591200.0	410702990.0	60.36
enterprise value	676797200.0	462999990.0	46.18
pe ratio	10.4	7.55	37.73
price to sales ratio	0.98	0.64	52.54
pocfratio	6.12	15.7	-61.04
pfcf ratio	9.11	-28.43	132.03
pb ratio	1.58	1.15	38.19
ptb ratio	1.58	1.15	38.19
ev to sales	1.01	0.73	39.05
enterprise value over ebitda	6.44	4.97	29.61
ev to operating cash flow	6.29	17.7	-64.48
ev to free cash flow	9.36	-32.05	129.20
earnings yield	0.1	0.13	-27.39
free cash flow yield	0.11	-0.04	412.17
debt to equity	0.17	0.25	-30.88
debt to assets	0.12	0.16	-24.40
net debt to ebitda	0.17	0.56	-69.13
current ratio	2.92	2.85	2.55
interest coverage	21.55	21.58	-0.14
income quality	1.7	0.48	253.50
dividend yield	0.01	0.01	-37.53
payout ratio	0.06	0.08	-13.96
sales general and administrative to revenue	0.11	0.11	0.98
research and ddevelopement to revenue	0.03	0.03	8.77
intangibles to total assets	0.07	0.07	-4.87
capex to operating cash flow	0.33	1.55	-78.86
capex to revenue	0.05	0.06	-17.22
capex to depreciation	1.87	2.47	-24.40
stock based compensation to revenue	0.01	0.01	2.41
graham number	156.52	134.36	16.49
roic	0.13	0.11	18.69
return on tangible assets	0.11	0.1	9.31
graham net net	4.31	-1.0	529.76
working capital	213498000	212835000	0.31
tangible asset value	373678000	316538000	18.05
net current asset value	137820000	118315000	16.49
invested capital	475539000	429932000	10.61
average receivables	116076500	111732000	3.89
average payables	42313500	44607500	-5.14
average inventory	148136000	130982500	13.10
days sales outstanding	58.26	71.77	-18.83
days payables outstanding	31.72	40.53	-21.73
days of inventory on hand	124.92	127.59	-2.10
receivables turnover	6.27	5.09	23.19
payables turnover	11.51	9.01	27.77
inventory turnover	2.92	2.86	2.14
roe	0.15	0.15	0.34
capex per share	7.18	8.23	-12.78

• Neutral

  ROE: Return on Equity (ROE) decreased to 0.15 on 2023-12-31 from 0.15 on 2022-12-31, representing a change of 0.34%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 10.40 on 2023-12-31 from 7.55 on 2022-12-31, representing a change of 37.73%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 2.92 on 2023-12-31 from 2.85 on 2022-12-31, representing a change of 2.55%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.17 on 2023-12-31 from 0.25 on 2022-12-31, representing a change of -30.88%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
PLPC
calendar year	2024	2024	NaN
revenue per share	29.97	28.22	6.19
net income per share	1.57	1.91	-17.82
operating cash flow per share	1.91	5.76	-66.82
free cash flow per share	1.18	5.0	-76.37
cash per share	9.69	9.65	0.38
book value per share	87.48	84.68	3.30
tangible book value per share	79.39	76.76	3.43
shareholders equity per share	87.47	84.68	3.30
interest debt per share	9.05	9.71	-6.79
market cap	628104320.0	597172500	5.18
enterprise value	624415320.0	596892500	4.61
pe ratio	20.45	15.94	28.27
price to sales ratio	4.27	4.3	-0.73
pocfratio	67.06	21.11	217.74
pfcf ratio	108.44	24.31	346.11
pb ratio	1.46	1.43	2.05
ptb ratio	1.46	1.43	2.05
ev to sales	4.25	4.3	-1.26
enterprise value over ebitda	38.27	35.16	8.84
ev to operating cash flow	66.67	21.1	216.02
ev to free cash flow	107.81	24.3	343.69
earnings yield	0.01	0.02	-22.04
free cash flow yield	0.01	0.04	-77.58
debt to equity	0.1	0.11	-9.84
debt to assets	0.07	0.08	-10.11
net debt to ebitda	-0.23	-0.02	-1270.71
current ratio	2.81	2.93	-4.13
interest coverage	18.43	19.88	-7.32
income quality	1.22	3.02	-59.71
dividend yield	0.0	0.0	-5.02
payout ratio	0.13	0.11	21.83
sales general and administrative to revenue	0.11	0.11	1.59
research and ddevelopement to revenue	0.04	0.04	-2.32
intangibles to total assets	0.07	0.07	-1.55
capex to operating cash flow	0.38	0.13	189.61
capex to revenue	0.02	0.03	-9.51
capex to depreciation	0.67	0.71	-5.50
stock based compensation to revenue	0.0	0.01	-36.13
graham number	55.52	60.26	-7.86
roic	0.02	0.02	-20.78
return on tangible assets	0.01	0.02	-20.77
graham net net	7.97	7.74	2.87
working capital	206645000	201089000	2.76
tangible asset value	389332000	377258000	3.20
net current asset value	157678000	148704000	6.03
invested capital	459847000	451084000	1.94
average receivables	106174000	106493500	-0.30
average payables	42685500	42346500	0.80
average inventory	142269000	141660000	0.43
days sales outstanding	67.9	65.83	3.16
days payables outstanding	37.73	40.92	-7.80
days of inventory on hand	126.94	135.13	-6.07
receivables turnover	1.33	1.37	-3.06
payables turnover	2.39	2.2	8.46
inventory turnover	0.71	0.67	6.46
roe	0.02	0.02	-20.44
capex per share	0.73	0.76	-3.92

• Negative

  ROE: Return on Equity (ROE) decreased to 0.02 on 2024-09-30 Q3 from 0.02 on 2024-06-30 Q2, representing a change of -20.44%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 20.45 on 2024-09-30 Q3 from 15.94 on 2024-06-30 Q2, representing a change of 28.27%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.10 on 2024-09-30 Q3 from 0.11 on 2024-06-30 Q2, representing a change of -9.84%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Neutral

  Current Ratio: Current Ratio decreased to 2.81 on 2024-09-30 Q3 from 2.93 on 2024-06-30 Q2, representing a change of -4.13%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 90.73 which is lower than current price 125.9, indicates the company may be overvalued.